Cargando…
Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
Gavi supports countries to introduce typhoid conjugate vaccine (TCV) with catch-up campaigns. Available TCVs are highly efficacious, equity-focused, and critical to curbing the expansion of antimicrobial resistance. Four Gavi-supported countries have introduced TCVs since 2018. In the wake of the CO...
Autores principales: | Russell, Allyson L, Hampton, Lee M, Sinha, Antara, Luquero, Francisco J, Abdelwahab, Jalaa’ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236508/ https://www.ncbi.nlm.nih.gov/pubmed/37274531 http://dx.doi.org/10.1093/ofid/ofad042 |
Ejemplares similares
-
Using Typhoid Conjugate Vaccines to Prevent Disease, Promote Health Equity, and Counter Drug-Resistant Typhoid Fever
por: Nampota-Nkomba, Nginache, et al.
Publicado: (2023) -
Diagnostics for Typhoid Fever: Current Perspectives and Future Outlooks for Product Development and Access
por: Sapkota, Jyotshna, et al.
Publicado: (2023) -
Taking on Typhoid: Eliminating Typhoid Fever as a Global Health Problem
por: Chen, Jessie, et al.
Publicado: (2023) -
Characterization of Typhoid Intestinal Perforation in Africa: Results From the Severe Typhoid Fever Surveillance in Africa Program
por: Birkhold, Megan, et al.
Publicado: (2023) -
Salmonella Combination Vaccines: Moving Beyond Typhoid
por: MacLennan, Calman A, et al.
Publicado: (2023)